The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 236.50
Bid: 235.00
Ask: 238.00
Change: 5.00 (2.15%)
Spread: 3.00 (1.277%)
Open: 232.50
High: 238.00
Low: 238.00
Prev. Close: 233.00
DATA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Announcement of Investor Seminar

11 Jan 2024 07:00

RNS Number : 3183Z
GlobalData PLC
11 January 2024
 

11 January 2024

 

GlobalData Plc

(AIM: DATA, "GlobalData", the "Group")

 

Full year trading update and announcement of Investor Seminar

 

GlobalData Plc, a leading data, analytics, and insights platform, today provides the following update on trading following the end of its financial year to 31 December 2023 ("FY2023").

 

Following its interim results on 31 July 2023, GlobalData continued to deliver strong profitable growth throughout the second half. For FY2023, the Group expects to deliver Group revenue of c.£273m (2022: £243m), reflecting annual growth of 12% (7% underlying), and adjusted EBITDA growth of 28% to c.£111m (2022: £86m), which is within range of market expectations for the year. EBITDA margin was strong at c.41% (2022: 36%).

 

On 21 December 2023, we announced the launch of our new growth plan and Group reorganisation to operate across three customer-focused divisions - Healthcare, Consumer, and Technology - and also the transaction to sell a minority stake in our Healthcare business, which accounted for c.36% of revenue, at a valuation of £1,115m, raising net cash proceeds of approximately £434m.The transaction, which will provide flexibility for accelerated value-creating M&A across the Group, is progressing in line with our expectations and we expect to complete in Q2 2024.

 

GlobalData will host an investor and analyst seminar to focus on the new growth strategy and the customer-focused divisions, as well as further information on the impact of the Healthcare transaction on 24 January 2024 at 2pm. Please register your interest to attend this event with globaldata@fticonsulting.com.

 

FY2023 results, in full, will be announced on 4 March 2024.

 

Mike Danson, Chief Executive Officer of GlobalData Plc, commented:

 

"Over the last year, GlobalData has continued to execute on its growth optimisation plan and provide its global customer base with mission-critical insights and analysis. The result of this is we exited 2023 with another period of strong profitable growth and an EBITDA margin of more than 40%.

 

As we look ahead, we enter 2024 with a new growth plan and operating structure, which when added to our strong financial position, allows GlobalData to pursue a more ambitious growth strategy across the three divisions and create substantial value over the medium term."

 

 

ENDS

 

 

ENQUIRIES

 

GlobalData Plc

Mike Danson, Chief Executive Officer

0207 936 6400

Graham Lilley, Chief Financial Officer

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

Panmure Gordon (Joint Broker)

0207 886 2500

Rupert Dearden

Dougie McLeod

Deutsche Numis Securities (Joint Broker)

Nick Westlake

Iqra Amin

 

0207 260 1000

FTI Consulting (Financial PR)

0203 727 1000

Edward Bridges

Dwight Burden

Emma Hall

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFAESSELSEDF
Date   Source Headline
27th Apr 20188:14 amRNSDirector/PDMR Shareholding
24th Apr 20181:14 pmRNSResult of General Meeting and AGM
29th Mar 20187:00 amRNSProposed Acquisition
26th Feb 20187:01 amRNSFinal Results For The Year Ended 31 December 2017
26th Feb 20187:00 amRNSPossible Acquisition
21st Dec 20174:44 pmRNSTransaction in Own Shares
14th Dec 20174:37 pmRNSTransaction in Own Shares
8th Dec 20171:45 pmRNSAcquisition of MEED Media FZ LLC
6th Oct 201711:59 amRNSResult of secondary placing
6th Oct 20177:00 amRNSProposed secondary placing of ordinary shares
11th Sep 20177:00 amRNSDirectorate Change
1st Aug 20177:00 amRNSRevised dividend timetable
31st Jul 20177:00 amRNSUnaudited Interim Report
13th Jun 20175:57 pmRNSTransaction in Own Shares
9th Jun 20179:53 amRNSTransaction in Own Shares
2nd Jun 20175:48 pmRNSTransaction in Own Shares
18th May 20175:40 pmRNSTransaction in Own Shares
11th May 20175:34 pmRNSTransaction in Own Shares
9th May 20173:02 pmRNSTransaction in Own Shares
25th Apr 201712:52 pmRNSAGM Result
25th Apr 20177:00 amRNSAGM Statement
19th Apr 20172:10 pmRNSNew Banking Facilities
24th Mar 20177:00 amRNSAnnual Report and Accounts and Notice of AGM
27th Feb 20177:02 amRNSAppointment of Non-Executive Directors
27th Feb 20177:00 amRNSFinal Results For The Year Ended 31 December 2016
30th Dec 201612:57 pmRNSTransaction in Own Shares
23rd Dec 20163:29 pmRNSTransaction in Own Shares
6th Dec 20165:27 pmRNSTransaction in Own Shares
15th Nov 201611:48 amRNSTransaction in Own Shares
11th Nov 20166:18 pmRNSTransaction in Own Shares
4th Nov 20168:48 amRNSTransaction in Own Shares
28th Oct 20165:23 pmRNSTransaction in Own Shares
21st Oct 20166:04 pmRNSGrant of Options
12th Oct 20166:06 pmRNSTransfer of Shares out of Treasury
23rd Sep 201610:28 amRNSDirector/PDMR Shareholding
25th Jul 20167:00 amRNSInterim Results
19th Jul 20169:49 amRNSNotice of Results
19th Jul 20167:00 amRNSDirector Notification
24th Jun 20164:52 pmRNSTransaction in Own Shares
13th Jun 201612:31 pmRNSTransaction in Own Shares
9th Jun 20169:16 amRNSTransaction in Own Shares
17th May 20163:41 pmRNSTransaction in own shares
17th May 201612:28 pmRNSResult of AGM
13th May 20165:01 pmRNSTransaction in Own Shares
18th Apr 20167:00 amRNSTransaction in Own Shares
31st Mar 20167:00 amRNSAnnual Report and Accounts and Notice of AGM
17th Mar 20166:12 pmRNSTransaction in Own Shares
11th Mar 20165:07 pmRNSDirector/PDMR Shareholding
8th Mar 20165:56 pmRNSDirector's Dealings
1st Mar 20167:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.